Family of Brands

We continue our discussion of the marketing challenges faced during mergers and acquisitions in the life sciences. In this issue, we return to the model we recently introduced, one that provides a way to ask and answer the key question that must be addressed during mergers, acquisitions and even product or service launches: How should the relationships among different brands in a common family be portrayed to the audience? We discuss the advantages and disadvantages of the four possible answers and provide guidance for choosing one answer over the other.

Mergers and acquisitions are a fact of life in the life sciences. As the drug development ecosystem – which was previously vertically integrated – fragments and as the industry consolidates, mergers will become even more common. Mergers and acquisitions raise some of the most interesting challenges in life science marketing. In this issue, we open our series on this fascinating topic by identifying the key question that the life science marketers involved in any merger or acquisition must answer. We also provide a framework to understand the four possible answers to the key question.